Novavax, ordinary share
US6700024010, NVAX

Name: Novavax (NVAX) Stock Price Quote
Creator: Cbonds
License: https://creativecommons.org/licenses/by/4.0/

Add a stock to WL

Choose all Reset all

Save Close

Novavax, сountry — USA

No trading data

Data display in a chart | table

Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".

from

ADD-IN
Cbonds add-in API
bond data api

Authorization required

You need to request access

More than 2,500 records have been found, please specify your request

No data for the selected period

Latest quotes

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way

Bond Search

Watchlist

Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Issuer

Profile

Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Headquartered in Gaithersburg, Maryland with additional facilities in Rockville, Maryland and Uppsala, Sweden. Novavax is a public company that trades under the symbol "NVAX"

Show more Hide

Issuer

Novavax
Full borrower / issuer name

Novavax, Inc.
Industry

Pharmaceutical Preparation and Biotechnology

Placement data

Placement type

SPO | Finished
Subscription type

Open
Placement exchange

NASDAQ
Ticker

NVAX
Placement

13.04.2018
Lock up period

180
Number of papers

30,303,050
Volume of raised funds

50 mln USD
Placement share

8.04%
Final placement price

1.65 USD
Price change since placement date

198.79%
By capitalization

622.14 mln USD

IFRS/US GAAP reports

2023
	I q eng
	II q eng
	III q eng
	IV q eng
2022
	I q eng
	II q eng
	III q eng
	IV q eng
2021
	I q eng
	II q eng
	III q eng
	IV q eng
2020
	I q eng
	II q eng
	III q eng
	IV q eng
2019
	I q eng
	II q eng
	III q eng
	IV q eng
2018
	I q eng
	II q eng
	III q eng
	IV q eng
2017
	I q eng
	II q eng
	III q eng
	IV q eng
2016
	I q eng
	II q eng
	III q eng
	IV q eng
2015
	I q eng
	II q eng
	III q eng
	IV q eng
2014



	IV q eng

Show all Hide

Authorization required

You need to request access

Related Stock indices

Indicators

News

22/04/2024	Novavax: Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits
28/02/2024	Novavax: Results Of Operations And Financial Condition, Financial Statements And Exhibits
16/02/2024	Novavax: Entry Into A Material Definitive Agreement, Termination Of A Material Definitive Agreement
30/01/2024	Novavax: Costs Associated With Exit Or Disposal Activities
08/01/2024	Novavax: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits

Novavax, ordinary share
US6700024010, NVAX

Stock information